These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 15533484)

  • 21. Management of the male urethra after cystectomy for bladder cancer.
    Sarosdy MF
    Urol Clin North Am; 1992 May; 19(2):391-6. PubMed ID: 1574829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indications for urethrectomy.
    Elmajian DA
    Semin Urol Oncol; 2001 Feb; 19(1):37-44. PubMed ID: 11246732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: a comparative retrospective study.
    Jaidane M; Bouicha T; Slama A; Hmida W; Hidoussi A; Ben Sorba N; Mosbah F
    Urology; 2010 Jun; 75(6):1392-5. PubMed ID: 19781747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and outcomes of urethral recurrence after orthotopic neobladder replacement in patients with bladder cancer - practice in a single centre.
    Zhou X; Ji H; Zhang H; Xiong T; Pan J; Chen Z
    J Int Med Res; 2018 Sep; 46(9):3928-3937. PubMed ID: 29936879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the ratio of urethral recurrence risk after radical cystoprostatectomy for bladder cancer?
    Sevin G; Soyupek S; Armağan A; Hoşcan MB; Dilmen C; Tükel O
    Int Urol Nephrol; 2004; 36(4):523-7. PubMed ID: 15787329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of the patient with bladder cancer. Urethral recurrence.
    Freeman JA; Esrig D; Stein JP; Skinner DG
    Urol Clin North Am; 1994 Nov; 21(4):645-51. PubMed ID: 7974896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer.
    Donat SM; Wei DC; McGuire MS; Herr HW
    J Urol; 2001 May; 165(5):1580-4. PubMed ID: 11342921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors and outcomes of urethral recurrence following radical cystectomy.
    Boorjian SA; Kim SP; Weight CJ; Cheville JC; Thapa P; Frank I
    Eur Urol; 2011 Dec; 60(6):1266-72. PubMed ID: 21871713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of cystoscopy, prostate biopsy and frozen-section urethral biopsy prior to orthotopic neobladder substitution.
    Bulbul MA; Wazzan W; Nasr R; Hemady K
    Can J Urol; 2001 Jun; 8(3):1290-2. PubMed ID: 11423017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic radical cystectomy for cancer: oncological outcomes at up to 5 years.
    Haber GP; Gill IS
    BJU Int; 2007 Jul; 100(1):137-42. PubMed ID: 17552961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors of urethral involvement of bladder cancer after radical cystectomy with orthotopic neobladder in females.
    Kochakarn W; Chaimuangraj S; Leenanupunth C; Muangman V
    J Med Assoc Thai; 2001 Jun; 84(6):889-92. PubMed ID: 11556471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urethral recurrence in patients following orthotopic urinary diversion.
    Hassan JM; Cookson MS; Smith JA; Chang SS
    J Urol; 2004 Oct; 172(4 Pt 1):1338-41. PubMed ID: 15371836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic radical cystectomy and extracorporeal urinary diversion: a single center experience of 48 cases with three years of follow-up.
    Hemal AK; Kolla SB; Wadhwa P; Dogra PN; Gupta NP
    Urology; 2008 Jan; 71(1):41-6. PubMed ID: 18242362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.
    Gupta NP; Kolla SB; Seth A; Hemal AK; Dogra PN; Kumar R
    J Urol; 2007 Oct; 178(4 Pt 1):1206-11; discussion 1211. PubMed ID: 17698145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robotic assisted laparoscopic radical cystoprostatectomy: operative and pathological outcomes.
    Pruthi RS; Wallen EM
    J Urol; 2007 Sep; 178(3 Pt 1):814-8. PubMed ID: 17631334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncological outcome after radical cystectomy and orthotopic bladder substitution in women.
    Ali-El-Dein B
    Eur J Surg Oncol; 2009 Mar; 35(3):320-5. PubMed ID: 18434072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of laparoscopic and open radical cystoprostatectomy for localized bladder cancer with 3-year oncological followup: a single surgeon experience.
    Hemal AK; Kolla SB
    J Urol; 2007 Dec; 178(6):2340-3. PubMed ID: 17936813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.